<DOC>
	<DOCNO>NCT02127892</DOCNO>
	<brief_summary>This pilot clinical trial hematopoietic stem cell transplantation patient diagnosis Severe Combined Immune Deficiency ( SCID ) HLA-matched sibling donor . The stem cell derive 1 ) match unrelated donor ( MUD ) , 2 ) unrelated cord blood donor , 3 ) haplo-identical ( parental ) donor ( descend order preference ) .Patients receive novel condition regimen Busulfan , Fludarabine Anti-thymocyte globulin ( ATG ) follow unrelated donor hematopoietic stem cell transplant ( HSCT ) T-cell depletion use CliniMACS device .</brief_summary>
	<brief_title>SCID Bu/Flu/ATG Study With T Cell Depletion</brief_title>
	<detailed_description>The study conduct assess following : - overall survival - event-free survival ( event define : death , non-engraftment/2nd transplant , immune reconstitution failure ) - acute toxicity condition regimen - engraftment frequency immune reconstitution frequency tempo acute chronic graft-versus-host disease ( GVHD ) , frequency severity . The outcome protocol compare retrospective cohort consist patient undergone haplo-identical HSCT SCID CHLA 1984-2006 base assessment above-listed endpoint . The CliniMACS device use CD34+ selection place Isolex 300i . The CliniMACS CD34 Reagent System investigational medical device yet approve FDA . This device use vitro select enrich specific cell population . When use CliniMACS CD34 Reagent , system selects CD34+ cell heterogenous hematological cell population transplantation case clinically indicate . Based gathered data , CliniMACS contribute factor toxicity patient , although , may potential elicit `` antibody '' reaction patient , process significant life-saving benefit compare potential risk .</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Severe Combined Immunodeficiency</mesh_term>
	<criteria>All patient SCID lack histocompatible sibling HLAmatched related donor consider candidate study protocol . Eligible patient must adequate physical function tolerate chemotherapy condition regimen HSCT , measure : 1 . Renal : creatinine clearance GFR â‰¥50 ml/min/1.73m2 , require dialysis 2 . Pulmonary : Because patient SCID frequently present infectious pneumonia cause ventilatory failure , patient consider enrollment study even respiratory failure require mechanical ventilatory support present . In patient recently diagnose pneumonia , effort stabilize respiratory status make prior enrollment study . 3 . Infectious disease status . The presence infection per se reason exclusion study . Patients SCID frequently infect routine pathogen well opportunistic infection . Antibiotic , antifungal antiviral prophylaxis therapy institute clinically indicate . Despite use antimicrobial therapy , ability control infection achieve unless HSCT perform . Therefore , subject may enrol study , even though infection present , control infection may depend engraftment donor immune system . 4 . Patients 021 year age . Patient histocompatible sibling relate donor Endorgan failure preclude ability tolerate transplant procedure , include conditioning . Renal failure require dialysis Congenital heart disease result congestive heart failure Severe CNS disease , e.g. , coma intractable seizure Ventilatory failure due noninfectious etiology Major congenital anomaly adversely affect survival , eg CNS malformation Metabolic disease would affect transplant survival , eg urea cycle disorder HIV infection Since chance survival patient SCID successful transplantation , patient SCID consider potential subject study , regardless endorgan dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Severe Combined Immune Deficiency</keyword>
	<keyword>SCID</keyword>
	<keyword>HLA-matched unrelated donor</keyword>
	<keyword>unrelated</keyword>
	<keyword>MUD</keyword>
	<keyword>bone marrow</keyword>
	<keyword>cord blood</keyword>
	<keyword>haplo-identical</keyword>
	<keyword>peripheral blood</keyword>
	<keyword>CD34+ selection</keyword>
	<keyword>T cell depletion</keyword>
	<keyword>HSCT</keyword>
	<keyword>BMT</keyword>
	<keyword>CliniMACS</keyword>
</DOC>